Remus Pharmaceuticals Limited — QIP/Rights/Pref., 07-07-2025: Allotment of Securities

Remus Pharmaceuticals has announced a board meeting and approved a 1:1 bonus share issue, allotting 58.92 lakh fully paid-up equity shares of ₹10 each to existing shareholders. This doubles the paid-up equity share capital from ₹5.89 Cr to ₹11.78 Cr. No fresh funds raised, but shareholder value per equity will adjust accordingly. Promoter holding percentage remains unchanged as this is a bonus issue to all existing shareholders.